This track offers practitioners in the data-driven, dynamic, disruptive field of structural heart disease the opportunity to catch-up on all the new patient choices that have emerged over the past 12 months. The skills and knowledge gained will help interventionalists hone the expertise necessary for practice today and prepare for the evolving field of tomorrow.
Taking a tiered approach to learning, the agenda expands out from the basics to cover the major, upcoming developments in the field. The agenda is quality-led and patient-centered, focusing on the need for training and best practices in all things technical in the cath lab.
This track combines on-demand learning with live presentations, offering step-by-step technical instruction and the opportunity to engage with faculty to those early in their career and more experienced operators wanting to add to their skillset.
After attending SCAI 2021, the learner will be able to:
- Discuss the pros and cons of a transcatheter versus surgical approach to severe aortic stenosis in special populations (i.e., bicuspid aortic valve, low surgical risk with low lying coronaries, high LVOT calcium burden)
- Evaluate the data on patient selection and technical considerations for transcatheter mitral valve repair, taking into consideration emerging repair platforms
- List controversies in structural heart disease care, and how upcoming clinical trials aim to address critical remaining questions (i.e., transcatheter repair of tricuspid regurgitation; transcatheter mitral valve replacement; and left atrial appendage closure in low-risk patients)
Speakers are chosen not only for their expertise, but also their skills as teachers and educators, will present a series of practical, easy-to-follow sessions on an array of topics, and clinical trial leaders will discuss the latest advances and research shaping the field.